Brendan Antiochos MD - Anti‐retinoblastoma Protein Antibodies: A New

Journal article

A. Goules, Jessica Li, B. Antiochos, D. Goldman, A. Rosen, M. Petri, L. Casciola‐Rosen
ACR Open Rheumatology, 2019

Semantic Scholar DOI PubMedCentral PubMed

Cite

APA Click to copy
Goules, A., Li, J., Antiochos, B., Goldman, D., Rosen, A., Petri, M., & Casciola‐Rosen, L. (2019). Anti‐retinoblastoma Protein Antibodies: A New Specificity in Systemic Lupus Erythematosus Associated With Protection Against Lupus Nephritis. ACR Open Rheumatology.

Chicago/Turabian Click to copy
Goules, A., Jessica Li, B. Antiochos, D. Goldman, A. Rosen, M. Petri, and L. Casciola‐Rosen. “Anti‐Retinoblastoma Protein Antibodies: A New Specificity in Systemic Lupus Erythematosus Associated With Protection Against Lupus Nephritis.” ACR Open Rheumatology (2019).

MLA Click to copy
Goules, A., et al. “Anti‐Retinoblastoma Protein Antibodies: A New Specificity in Systemic Lupus Erythematosus Associated With Protection Against Lupus Nephritis.” ACR Open Rheumatology, 2019.

BibTeX Click to copy

@article{a2019a,
  title = {Anti‐retinoblastoma Protein Antibodies: A New Specificity in Systemic Lupus Erythematosus Associated With Protection Against Lupus Nephritis},
  year = {2019},
  journal = {ACR Open Rheumatology},
  author = {Goules, A. and Li, Jessica and Antiochos, B. and Goldman, D. and Rosen, A. and Petri, M. and Casciola‐Rosen, L.}
}

Abstract

Retinoblastoma (Rb) protein is a nuclear protein with several important functions, including the ability to stabilize heterochromatin. Because antibodies against the nucleosome and chromatin are key in systemic lupus erythematosus (SLE), we sought to determine whether Rb was an autoantigen in SLE and to evaluate any associated clinical phenotypes.